FINANCIAL INTEREST
DISCLOSURE REQUIREMENTS
|
|
STATE |
FEDERAL |
|
Reporting Triggers |
▪
Research contract/grant from a
non-governmental entity (including
the industry sponsor match for UC Discovery Grants) ▪
Gift (earmarked
specifically for research or for a specific PI) ▪
Material Transfer Agreement
(when the MTA constitutes a request
to support research) ▪
Proposed License Agreement
(if lead
inventor has a financial interest in the licensee) Note: Some
non-governmental sponsors are exempted from the disclosure requirements. See exempt list. |
▪
Federal research contract/grant ▪
Non-governmental entity which flows down federal
funds (excluding SBIR/STTR Phase I awards) ▪ Grant
from the American Cancer Society or American Heart Association ▪ UC
Discovery Grants ▪
UC Special Research Programs (HIV/AIDS,
breast cancer, and tobacco-related disease) ▪ CIRM |
|
Who Must Disclose |
▪
UCLA Principal Investigator(s) ▪
Other Investigators (UCLA employee who shares
responsibility for design, conduct, or reporting of the results of a
sponsored project) ▪
Lead UCLA Inventor |
▪
UCLA Principal Investigator(s) ▪
Other Investigators (UCLA employee who shares responsibility for
design, conduct, or reporting of the results of a sponsored project) |
|
What to Disclose |
For the PI:
A financial interest in the sponsor of the research, or
candidate licensee including: ▪ Income ³ $500 ▪
Investments ³ $2,000 ▪
Director, Officer, Employee, Partner,
Trustee, Consultant or Management position (paid or unpaid) ▪
Loan balances ³
$500 ▪
Gifts valued at ³
$50 ▪
Travel For
Other Investigators: A
significant financial interest in the sponsor of the research
including:
▪
Income ³ $10,000 ▪
Equity ³ $10,000 or 5% ▪
Director, Officer, Employee, Partner,
Trustee, Consultant or Management position (paid or unpaid) ▪
Intellectual property Note: Financial
interests must be reported for the discloser and his/her spouse or registered
domestic partner, and dependent children.
|
A
significant financial interest related to the research project,
including: ▪
Income ³ $10,000 ▪
Equity ³ $10,000 or 5% ▪
Director, Officer, Employee, Partner,
Trustee, Consultant or Management position (paid or unpaid) ▪
Intellectual property Note: Financial interest must be reported for the
discloser and his/her spouse or registered domestic partner, and dependent
children. |
|
When to Disclose |
▪
With the initial proposal ▪
With additional funding Note:
All positive disclosures must be reviewed and approved prior to acceptance
of the award or additional funding. ▪
Upon identification of one or more
candidate licensee companies (possibly prior to the signing of any secrecy
agreement) |
▪
With all competing proposals (new & renewal) ▪
With non-competing continuations (PHS only) ▪
With requests for no-cost time extensions ▪
With supplemental funding ▪
When new personnel are added ▪
Whenever there is a change in an Investigator’s
interest Note: All positive disclosures
must be reviewed and approved prior to acceptance of the award or additional
funding, or prior to new personnel joining the project. |
|
Disclosure Forms |
Principal Investigator: ▪
State Form 700-U
▪
Supplement* (if positive) *For Clinical
Trials, complete Industry
Clinical Trial Specific Disclosure Supplement online smart form Other Investigators: ▪
Supplement* (if positive) *For Clinical
Trials, complete Industry
Clinical Trial Specific Disclosure Supplement online smart form Lead Inventor |
All Principal Investigators and Other Investigators: ▪
UCLA
Form 740 Supplement (if
positive) |
Definitions:
Key
Position/Management Position includes any position of management, whether
paid or unpaid, including director, officer, partner, trustee, consultant,
employee, or board member.
Income includes but is not
limited to salaries, wages, advances, dividends, interest, rent, proceeds from
sale, gifts (incl. food & beverage), loan forgiveness, expense
reimbursement, per diem, contributions to insurance/pension programs,
outstanding loans.
Investments include any direct, indirect or beneficial financial
interest in a business, stocks, bonds, warrants, options.
Gifts are anything of value for which equal or greater
consideration have not been provided.
Gifts commonly include:
tickets/passes to sporting or entertainment events or amusement parks;
parking passes; food, beverages and accommodations including that provided in
direct connection with attendance at a convention, conference, meeting, social
event, meal, or like gathering, where a speech, participation in a panel or
seminar, or similar service was not provided; rebates/discounts not made in the
regular course of business to members of the public; wedding gifts; honoraria
(honoraria may be reported as income if the services provided were of
equal or greater value than the payment received); transportation and lodging;
and forgiveness of a loan received by the discloser.
Travel includes advances and reimbursements for travel and
related expenses, including lodging and meals.
Travel payments are considered gifts if no services equal to or
greater in value than the payments received are provided. Gifts of travel ³$50 must be disclosed (a description and dates must be
provided). Travel payments are
considered income if services equal to or greater in value than the
payments received are provided. Travel
income ³$500 must be disclosed (a
description of the services must be provided; dates are not required to be
disclosed for travel income). Disclosure
is not required for: payments for
transportation within California in connection with an event in which a speech,
participation in a panel or seminar, or similar service was provided; food,
beverages and necessary accommodations received directly in connection w/an
event held inside or outside California at which a speech, participation in a
panel, or similar service was provided (payments for transportation outside
California are reportable); payments from 501(c)(3) nonprofit entities for
which services of equal or greater consideration are provided.
For further information on
financial conflicts of interest in research, see UCLA Policy
925 and UCLA Procedures 925.1,
925.2,
and 925.3.